Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RITAI Cohort. An Observational Study on Serious Adverse Events Occuring After Rituximab Off-label Use for Auto-immune Disorders

NCT00960713 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00960713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00960713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RITAI Cohort. An Observational Study on Serious Adverse Events Occuring After Rituximab Off-label Use for Auto-immune Disorders
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
January 31, 2012
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

auto-immune thrombocytopenic purpura, cold agglutinin disease, cryoglobulinemia, hemolytic auto-immune anaemia, pemphigus